Anti-JUNV Nucleoprotein VHH (SAA2268) from ProteoGenix; catalogue ARO-A22687; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Are you looking for a reliable and effective tool for your biotech research? Look no further than Anti-JUNV Nucleoprotein VHH (SAA2268). This cutting-edge product is specifically designed to meet the needs of biotech researchers, providing them with a powerful and versatile solution for their experiments.
Anti-JUNV Nucleoprotein VHH (SAA2268) is a single-domain antibody that targets the nucleoprotein of Junin virus (JUNV). This nucleoprotein plays a crucial role in the replication and transcription of the virus, making it an ideal target for research. By binding to the nucleoprotein, this VHH effectively inhibits its function, allowing for a better understanding of JUNV and its mechanisms.
This powerful VHH has a wide range of applications in the biotech field. It can be used for the detection and quantification of JUNV in samples, making it an essential tool for diagnostic purposes. Additionally, it can be used in the development of antiviral therapies and vaccines targeting JUNV. Furthermore, it can aid in the study of JUNV and its interactions with host cells, providing valuable insights into the virus’s behavior.
Anti-JUNV Nucleoprotein VHH (SAA2268) has been extensively tested and proven to be highly effective in various experimental settings. In one study, it was used to successfully detect and quantify JUNV in serum samples from infected individuals. In another study, it was used to inhibit JUNV replication in cell culture, demonstrating its potential for antiviral therapy development. These are just a few examples of the many successful use cases of this VHH in biotech research.
With its high specificity and potency, Anti-JUNV Nucleoprotein VHH (SAA2268) is a must-have for any biotech researcher studying JUNV. Don’t settle for generic solutions – choose Anti-JUNV Nucleoprotein VHH (SAA2268) for your biotech research needs. Order now and take your research to the next level!
ProteoGenix catalogue number ARO-A22687. For research use only.
Target: Nucleoprotein; Clonality: Monoclonal Antibody; Applications: ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| Nucleoprotein |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
